Chong Kun Dang looks to the future

Published: 2003-10-15 06:59:00

Updated: 2003-10-15 06:59:00

"To maximize the chances of discovering breakthrough products within the constraint of scarce resources has been extremely difficult to us in face of uncertainties and tremendous R&D outlays but we managed to achieve our 10-year goal based on the company's long-term expertise and researchers' fir...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK